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Introduction
Adaptive immune responses are initiated upon recognition   
by the T cell receptor (TCR) of peptide antigen–major histo-
compatibility complex complexes, displayed on the surface of   
antigen-presenting cells. TCR engagement induces a coordi-
nated redistribution of receptors and signaling proteins at the 
immunological synapse, i.e., the interface between the T cell 
and the antigen-presenting cells (Monks et al., 1998; Grakoui 
et al., 1999). These events have been analyzed with high spa-
tial and temporal resolution by imaging T cells activated on 
artificial stimulatory surfaces, such as coverslips coated with 
anti-CD3 antibodies (Bunnell et al., 2002) or lipid bilayers 
containing  major  histocompatibility  complex–peptide  com-
plexes and adhesion molecules (Campi et al., 2005; Yokosuka 
et al., 2005). These approaches have revealed the assembly of 
submicrometer-scale  protein  complexes,  or  microclusters, 
containing the TCR and critical signaling molecules, includ-
ing the protein kinases LCK and ZAP70, the adaptors SLP76, 
GADS, GRB-2, and LAT, and downstream effectors, such as 
VAV1,  PLC-1,  and  Wiskott–Aldrich  syndrome  protein 
(Bunnell et al., 2002; Barda-Saad et al., 2004; Campi et al., 
2005; Yokosuka et al., 2005; Carrizosa et al., 2009; Miletic   
et al., 2009). After T cell spreading over the stimulatory surface, 
TCR-containing microclusters enriched in activating kinases 
(e.g.,  LCK  and  ZAP70)  and  excluding  negative  regulators   
(e.g., the phosphatase CD45) preferentially form at the periph-
ery of the immunological synapse. They then engage in cen-
tripetal  movements  toward  the  synapse  center  (Yokosuka   
et al., 2005; Varma et al., 2006). Microcluster components 
undergo different fates during this travel. TCRs accumulate at 
A
ntigen  recognition  within  immunological  syn-
apses triggers and sustains T cell activation by 
nucleating protein microclusters that gather T cell 
receptors (TCRs), kinases, and adaptors. Dissipation of 
these microclusters results in signal termination, but how 
this process is regulated is unclear. In this paper, we   
reveal  that  release  of  the  adaptors  SLP76  and  GADS   
from  signaling  microclusters  is  induced  by  the  serine/ 
threonine protein kinase HPK1 and that phosphorylation 
of GADS plays a major role in this process. We found   
that  HPK1  was  recruited  into  microclusters  and  trig-
gered their dissipation by inducing the phosphorylation 
of a threonine-containing motif of GADS, together with   
the  previously  described  serine  phosphorylation  of   
SLP76. These events induced the cooperative binding of 
14-3-3 proteins to SLP76–GADS complexes, leading to 
their  uncoupling  from  the  transmembrane  adaptor  LAT 
and  consequently  reducing  microcluster  persistence   
and activation-induced gene transcription. These results   
demonstrate that serine/threonine phosphorylation of   
multiple  TCR-proximal effectors controls the stability of 
signaling microclusters, thereby determining the intensity 
of T cell responses.
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Results
HPK1 overexpression affects  
SLP76 microclusters
To address whether HPK1 may alter the formation and/or the 
dynamics of SLP76 signaling complexes, we analyzed SLP76-
containing microclusters induced by immobilized stimulatory 
antibodies. SLP76-deficient J14 cells stably reconstituted with a 
YFP-tagged SLP76 fusion protein (J14-SLP76-YFP; Lasserre 
et al., 2010) were transiently transfected with a wild-type (WT) 
HPK1 construct fused to the red fluorescent protein mCherry 
(HPK1-mCherry). These cells were dropped on anti-CD3–
coated coverslips, and protein microclusters were imaged in 
fixed  cells  after  3-min  stimulation.  Microclusters  containing 
SLP76-YFP were detected in most untransfected cells, as ex-
pected, whereas their number was dramatically reduced in cells 
expressing HPK1-mCherry (Fig. 1 A). Conversely, transfection 
of  an  mCherry-labeled  kinase-deficient  mutant  of  HPK1 
(HPK1-KD-mCherry) led to an increase in the number of SLP76 
microclusters compared with control cells (Fig. 1 B), indicating 
that the impairment of SLP76 microclusters by HPK1 was de-
pendent on its catalytic activity.
Interestingly, HPK1-KD-mCherry clearly accumulated in 
SLP76-containing microclusters (Fig. 1 B). Thus, we asked 
whether HPK1 recruitment into microclusters was a prerequi-
site for their negative regulation. Phosphorylation of Tyr379 of 
HPK1 has been shown to allow binding of this kinase to the 
SH2 domain of SLP76 (Sauer et al., 2001). Hence, we trans-
fected an HPK1-mCherry construct bearing a Y379F mutation 
in J14-SLP76-YFP cells. As shown in Fig. 1 C, this mutant was 
not incorporated into microclusters nor affected their number, 
suggesting  that  Tyr379-dependent  interaction  of  HPK1  with 
SLP76 is a critical step in down-regulating SLP76 micro-
clusters. Thus, these data revealed that HPK1 regulates signaling 
microclusters and demonstrated that this function depends on 
HPK1 directly binding to SLP76 and catalytic activity.
HPK1 negatively regulates the persistence 
of SLP76-containing microclusters
To understand whether HPK1 overexpression prevents the for-
mation of signaling microclusters and/or reduces their stability 
after  initial  assembly,  J14-SLP76-YFP  cells  transfected  with 
HPK1-mCherry constructs were stimulated on anti-CD3–coated 
coverslips and imaged in real time. In control cells expressing 
only endogenous HPK1, SLP76 microclusters appeared as soon 
as cells touched the stimulatory surface and could be observed 
for a few minutes after cells had completely spread (Fig. 2 A and 
Video 1, bottom cell) as previously described (Bunnell et al., 
2002; Lasserre et al., 2010). Interestingly, in cells overexpress-
ing HPK1-mCherry, microclusters formed as in control cells 
during spreading on the stimulatory surface, but they rapidly dis-
appeared thereafter (Fig. 2 A and Video 1, top cell). Quantifica-
tion  of  the  lifetime  of  individual  microclusters  showed  that 
overexpression of HPK1 significantly reduces their persistence 
compared with untransfected cells (Fig. 2 B). The rarity of micro-
clusters in HPK1-overexpresing cells rendered the incorpora-
tion of HPK1-mCherry in SLP76 microclusters hard to detect 
the center of the synapse forming the so-called central supra-
molecular  activation  cluster  (cSMAC;  Monks  et  al.,  1998;   
Yokosuka  et  al.,  2005)  and  are  eventually  down-regulated 
(Varma et al., 2006; Vardhana et al., 2010). On the other hand, 
molecules such as SLP76 and ZAP70 segregate from TCR   
microclusters before they reach the cSMAC (Bunnell et al., 
2002; Yokosuka et al., 2005). Interestingly, reducing the mo-
bility of microclusters toward the cSMAC by different means 
results in increased microcluster persistence and T cell acti-
vation (Mossman et al., 2005; Nguyen et al., 2008; Lasserre et al., 
2010), suggesting that dynamic segregation of microcluster 
components reflects signal termination. Although ubiquity-
lation-mediated internalization/degradation of TCR subunits 
or other microcluster components has been implicated in sig-
nal inactivation (Balagopalan et al., 2007; Vardhana et al., 
2010), the mechanisms triggering protein sorting from micro-
clusters and signal termination are poorly characterized.
The cytoplasmic scaffold protein SLP76 plays a central 
role in TCR signal transduction and is indispensable for both 
thymocyte development and mature T cell activation (Koretzky 
et al., 2006). SLP76 is recruited into microclusters by binding 
to the transmembrane phosphoprotein LAT via the small adaptor 
GADS  (Liu  et  al.,  1999;  Bunnell  et  al.,  2006).  The  LAT–
GADS–SLP76 complex is pivotal for signaling regulation and 
diversification because it coordinates the recruitment and acti-
vation of effectors belonging to several downstream pathways 
(Acuto et al., 2008). For instance, the association of SLP76 
with the guanine nucleotide exchange factor VAV1, the adap-
tors NCK (Bubeck Wardenburg et al., 1998) and adhesion- and 
degranulation-promoting  adaptor  protein,  (Peterson  et  al., 
2001; Wang et al., 2009), the Tyr kinase Itk (Bunnell et al., 
2000), and the Ser/Thr kinase HPK1 allows it to control actin 
cytoskeleton remodeling, cell adhesion, and gene transcription 
(Koretzky et al., 2006).
Recently, we have unveiled a negative feedback loop in-
volving SLP76 that modulates T cell activation. HPK1 phosphory-
lates Ser376 of SLP76 and induces its interaction with members 
of the 14-3-3 protein family (Di Bartolo et al., 2007), ubiquitous 
molecules that regulate multiple cellular functions (Tzivion and 
Avruch, 2002). Biochemical and functional analyses suggested 
that binding of 14-3-3 to SLP76 down-modulates T cell signaling 
and activation (Di Bartolo et al., 2007), although the underlying 
mechanism remained uncharacterized. In support of our model, 
HPK1-deficient T cells showed increased signaling and respon-
siveness upon TCR stimulation (Shui et al., 2006).
Here, we demonstrate that HPK1 negatively regulates   
T cell activation by reducing the persistence of signaling micro-
clusters  and  identify  a  threonine-containing  motif  in  GADS 
whose phosphorylation plays a central role in this regulatory 
process. Our results indicate that HPK1-dependent phosphory-
lation of both GADS and SLP76 is required for the recruitment 
of 14-3-3 proteins. The resulting SLP76–GADS–14-3-3 com-
plexes  are  released  from  LAT-containing  microclusters  and 
likely  inactivated,  thus  down-modulating  T  cell  activation. 
These data define a novel mechanistic link between Ser/Thr 
phosphorylation of TCR effectors, stability of signaling protein 
complexes, and down-regulation of T cell responses.841 HPK1 regulates T cell microcluster stability • Lasserre et al.
HPK1-mCherry transfectants after the extinction of the initial 
wave of microclusters accompanying cell spreading (Fig. 2 A 
and Video 1). This observation suggested that HPK1 not only 
promotes dissociation of SLP76 from existing complexes but 
also prevents its incorporation into new ones. Contrary to the 
WT  construct,  HPK1-KD-mCherry  was  incorporated  into 
SLP76  microclusters  and  induced  a  significant  increase  in 
their mean lifetime (Fig. 2 B and Video 2), confirming that 
dissipation of SLP76 microclusters requires a catalytically   
active HPK1.
(Video 1). However, when visible, it was delayed as compared 
with microcluster formation. For instance, Fig. 2 C demonstrates 
that SLP76 incorporation increased for 40 s after microcluster 
detection, whereas HPK1-mCherry recruitment started to be de-
tectable when the amount of SLP76 was at its maximum. Inter-
estingly, the amount of SLP76 in microclusters started decreasing 
when HPK1 recruitment began, arguing that incorporation of 
HPK1 in SLP76 microclusters induces their dissipation.
Remarkably, continuous generation of new microclusters 
was detectable for some minutes in control cells but not in 
Figure 1.  HPK1 overexpression affects SLP76 microclusters. (A) J14-SLP76-YFP cells were transfected with HPK1-mCherry. The day after transfection, cells 
were activated for 3 min on anti-CD3–coated coverslips, fixed, and analyzed by confocal microscopy. A single optical section at the level of the contact 
surface is shown. The plot shows the number of microclusters in cells expressing or not expressing the HPK1-mCherry construct. (B) J14-SLP76-YFP cells were 
transfected with HPK1-KD-mCherry and analyzed as in A. (C) J14-SLP76-YFP cells were transfected with HPK1-Y379F-mCherry and analyzed as in A. For 
all panels, images are representative of more than three independent experiments. Horizontal lines and error bars show means and SEM. Bars, 5 µm.JCB • VOLUME 195 • NUMBER 5 • 2011   842
Figure 2.  HPK1 reduces the persistence of SLP76 microclusters. (A) J14-SLP76-YFP cells transfected with HPK1-mCherry were activated on anti-CD3–coated 
coverslips and imaged with a spinning-disk confocal microscope at one image/20 s. Frames from Video 1 at different time points are shown. One untrans-
fected control (CTRL) cell (closed arrowhead) and one cell expressing HPK1-mCherry (open arrowhead) are visible in each frame. (B). Lifetime of single 
SLP76-YFP microclusters was determined by manual tracking using time-lapse images of J14-SLP76-YFP cells, acquired as described in A. The plot shows 
SLP76 microcluster lifetime in untransfected cells and in cells expressing HPK1-mCherry or HPK1-KD-mCherry. (C, top) Z projection of the HPK1-mCherry– 
expressing cell shown in A, imaged after 80 s of activation. The boxed area highlights a microcluster containing both SLP76-YFP (green) and HPK1-mCherry 
(red). (bottom) Magnification of the boxed area shown in the top image at different time points. Time 0 corresponds to the first detection of this SLP76-YFP 
microcluster (i.e., 40 s in the time lapse displayed in A). Similar results were obtained in three independent experiments. (D) J14-SLP76-YFP cells transfected 
with control (siCont) or HPK1-specific (siHPK1) siRNAs were stimulated on anti-CD3 coverslips and analyzed as described in A. Knockdown efficiency was 
assessed by flow cytometry (Fig. S1). (E) SLP76 microcluster lifetime assessed in cells treated as in D. The plot shows pooled data of three experiments. 
Horizontal lines and error bars show means and SEM. Bars: (A, C [top], and D) 5 µm; (C, bottom) 1 µm.843 HPK1 regulates T cell microcluster stability • Lasserre et al.
clustering of SLP76, although it may exert some delayed effect 
on phospho-LAT microclusters.
Further insight into the mechanism by which HPK1 af-
fects SLP76 microclusters was obtained by analyzing SLP76- 
associated proteins by coimmunoprecipitation in cells stably 
expressing a FLAG-SLP76 construct (J14-SLP76-WT; Di Bartolo 
et al., 2007). HPK1 silencing increased the amount of LAT co-
precipitating with SLP76 in anti-CD3–stimulated cells, whereas 
the amount of coprecipitating GADS was unaffected (Fig. 3 G, 
compare bottom and middle). Efficient HPK1 silencing and im-
paired phosphorylation of its substrate Ser376 were confirmed by 
Western blotting (Fig. S3 A). Conversely, transient cotransfection 
of HPK1 with FLAG-SLP76 in J14 cells impaired the activation- 
induced coprecipitation of LAT but not GADS with FLAG-SLP76 
at 5 min of stimulation (Fig. 3 G), although LAT phosphorylation 
was not affected (Fig. S3 B). Together, these results demonstrated 
that HPK1 controls the persistence of SLP76 microclusters by   
uncoupling SLP76–GADS complexes from phosphorylated LAT.
Persistence of SLP76 microclusters is 
partially dependent on HPK1-induced 
binding of 14-3-3 proteins to SLP76
Because  we  previously  showed  that  HPK1  phosphorylates 
Ser376 of SLP76 and induces its binding to 14-3-3 proteins   
(Di Bartolo et al., 2007), we probed the involvement of these 
events in the dissipation of SLP76 microclusters. First, we com-
pared the distribution of SLP76 microclusters and SLP76–14-3-3 
complexes in SLP76-YFP–expressing cells. SLP76–14-3-3 
complexes were specifically detected in activated cells by using 
an in situ proximity ligation assay (PLA; Fig. S4, A and B; see 
Materials and methods and Söderberg et al., 2006) but appeared 
to be segregated from SLP76-YFP microclusters (Fig. 4 A, top). 
Although the latter were adjacent to the cell–coverslip interface, 
SLP76–14-3-3 complexes were mostly far from this region 
(Fig.  4  A,  bottom).  Accordingly,  only  SLP76  microclusters, 
which are localized in close proximity of the plasma membrane, 
could be detected by total internal reflection fluorescence (TIRF) 
microscopy,  whereas  SLP76–14-3-3  complexes  were  visible 
only by epifluorescence (Fig. S4 C). These data strongly suggest 
that 14-3-3 binding to SLP76 and retention of SLP76 in micro-
clusters are mutually exclusive.
Additionally, the number of microclusters was significantly 
increased in cells expressing a YFP-labeled SLP76-S376A mu-
tant, which cannot bind 14-3-3 proteins (Fig. 4 B). This result, 
implicating the SLP76–14-3-3 interaction in the regulation of 
SLP76 microclusters, was reminiscent of the effect of HPK1 
knockdown (Fig. 3). However, the latter produced larger effects 
than SLP76-S376A-YFP expression (63 vs. 29% increase in 
microclusters compared with control cells, respectively, at 3 min 
of stimulation; compare Figs. 3 C and 4 B), suggesting that HPK1 
may exert additional effects on these signaling complexes.
Based on the propensity of 14-3-3 proteins to form homo- 
or heterodimers simultaneously binding two phosphorylated 
motifs (Tzivion and Avruch, 2002), we hypothesized that HPK1 
might generate a second 14-3-3 binding site in SLP76 or in an 
associated  protein,  stabilizing  the  interaction  with  Ser376. 
Hence,  we  probed  SLP76-associated  proteins,  isolated  from 
We then addressed the role of endogenous HPK1 by analyz-
ing the effect of HPK1 silencing on the persistence of SLP76   
microclusters  in  live  cells.  SLP76-YFP–expressing  cells  were 
transfected with control or HPK1-specific siRNA oligonucleo-
tides, typically yielding a knockdown efficiency of >70%   
(Fig. S1). Reduced HPK1 expression correlated with an increased 
lifetime of SLP76 microclusters (Fig. 2, D and E), similar to the 
effect of overexpressing HPK1-KD-mCherry (see previous para-
graph and Fig. 2 B). It is noteworthy that changes in SLP76 ex-
pression were not detected upon overexpression or silencing of 
HPK1 (Fig. S1, B and C); hence, they cannot explain the observed 
effect on SLP76 microclusters.
The dynamics of SLP76 microclusters was also studied in 
cells stimulated by superantigen-pulsed primary dendritic cells. 
J14-SLP76-YFP cells transfected with control or HPK1-specific 
siRNAs were dropped on a monolayer of human dendritic cells, 
previously  loaded  with  the  bacterial  superantigen  SEE,  and   
imaged in real time. Even in this setting, more closely reproduc-
ing physiological conditions, HPK1 knockdown appeared to 
extend  the  persistence  of  SLP76  microclusters  as  compared 
with control cells (Videos 3 and 4). Altogether, these results   
indicated that HPK1 plays a key role in controlling the persis-
tence  of  SLP76  microclusters  and  limiting  their  generation   
upon sustained TCR stimulation.
HPK1 uncouples SLP76 from  
phospho-LAT microclusters
SLP76 is constitutively associated to the adaptor GADS and is 
recruited into microclusters via the inducible interaction of GADS 
with phosphorylated LAT. Thus, to dissect the mechanism under-
lying the HPK1-induced dissipation of SLP76 microclusters, we 
compared the effect of HPK1 silencing on the number of SLP76 
and phospho-LAT microclusters. J14-SLP76-YFP cells were 
transfected with control or HPK1-targeting siRNAs, stimulated 
on anti-CD3–coated coverslips, and stained with phosphospecific 
antibodies against Tyr191 of LAT. SLP76 microclusters were 
comparable in numbers in HPK1-silenced and control cells for ≤2 
min of stimulation (Fig. S2 A). However, they were significantly 
more abundant in HPK1 knockdown than in control cells at 3 min 
of stimulation and later (Fig. 3, A and B). On the other hand, 
phospho-LAT microclusters were not affected by HPK1 knock-
down for ≤3 min, whereas their number declined thereafter with 
a delayed kinetics in HPK1-silenced compared with control cells 
(Fig. 3, A and C). A similar delay between SLP76 and LAT   
microcluster down-regulation was observed in primary human   
T cells transfected with HPK1-specific siRNAs. Higher numbers 
of phospho-SLP76 microclusters were detected in HPK1 knock-
down cells at 3 and 5 min of stimulation compared with control 
cells (Fig. 3, D and E), whereas phospho-LAT microclusters were 
slightly affected only at 5 min (Fig. 3 F). Mean HPK1 knock-
down efficiency in these cells was 60% (Fig. S2 B).
Consistent with these results, transfection of J14-SLP76-
YFP cells with HPK1-mCherry led to a significant reduction in 
the number of SLP76 microclusters compared with control cells 
but had no significant effect on phospho-LAT microclusters   
in cells stimulated for 3 min (Fig. S2, C and D). Collectively,   
these data indicated that the primary role of HPK1 is to regulate JCB • VOLUME 195 • NUMBER 5 • 2011   844
Figure 3.  HPK1 uncouples SLP76 from LAT microclusters. (A) J14-SLP76-YFP cells transfected with control (siCont) or HPK1-specific (siHPK1) siRNAs were 
activated for 3 min on anti-CD3–coated coverslips, fixed, stained with antiphospho-LAT (Y191) mAbs, and imaged by confocal microscopy. Results are 
representative of three independent experiments. (B and C) J14 cells expressing SLP76-YFP were transfected as in A and stimulated for the indicated time 845 HPK1 regulates T cell microcluster stability • Lasserre et al.
identified GADS as a novel 14-3-3–interacting protein and sug-
gested its potential involvement in mediating HPK1 regulation 
of signaling microclusters.
HPK1 phosphorylates GADS and regulates 
its interaction with 14-3-3 proteins
The aforementioned results prompted us to ask whether HPK1 
may regulate 14-3-3 binding to GADS. First, we used an in vitro 
J14-SLP76-WT cells, with a GST–14-3-3 fusion protein in an 
overlay assay. In addition to SLP76, a protein of 40 kD was 
bound by GST–14-3-3 but not by GST (Fig. 4 C, middle and 
left). This interaction was detectable in unstimulated cells and was 
increased after stimulation. Immunoblotting identified this protein 
as GADS (Fig. 4 C, right). Similar results were obtained when 
the GST–14-3-3 overlay assay was performed on SLP76 immuno-
precipitates from human CD4
+ T cells (Fig. 4 D). These results 
points. SLP76-YFP (B) and phospho-LAT (p-LAT; C) microclusters were imaged and automatically counted (see Materials and methods). Circles represent the 
number of microclusters/cell of pooled data from three independent experiments. (D) Human primary CD4
+ T cells, transfected with control or HPK1-specific 
siRNAs, were activated as in A, fixed, and stained with antiphospho-SLP76 (Y128) and antiphospho-LAT (Y191) mAbs. Images were acquired as in A. 
HPK1 knockdown efficiency was assessed by flow cytometry (Fig. S2 B). (E and F) Human primary CD4
+ T cells were transfected and stimulated as in D 
and fixed at the indicated time points. Phospho-SLP76 (p-SLP76) and phospho-LAT microclusters were counted as in B. (G) J14-SLP76-WT cells expressing 
FLAG-SLP76 and transfected with control or HPK1-specific siRNAs were stimulated by anti-CD3 antibodies for the indicated time points, lysed, and immuno-
precipitated (IP) by the anti-FLAG mAb. Proteins were separated by electrophoresis in nonreducing conditions and analyzed by immunoblotting (IB) as 
indicated. Comparable results have been obtained in two independent experiments. See Fig. S3 A for analysis of HPK1 knockdown efficiency. (H) J14 cells 
transiently transfected with SLP76-FLAG and/or HPK1-MYC constructs were stimulated for the indicated time points, lysed, and immunoprecipitated by anti-
FLAG antibodies. Proteins were analyzed by immunoblotting as in G. Mobility of molecular mass markers (in kilodaltons) is shown on the left. Horizontal 
lines and error bars show means and SEM. Bars, 5 µm.
 
Figure 4.  Persistence of SLP76 microclusters is partially dependent on 14-3-3 proteins binding to phosphorylated Ser376. (A) J14-SLP76-YFP cells were 
activated for 3 min on anti-CD3–coated coverslips, fixed, and stained with anti-SLP76 and anti–14-3-3 antibodies. SLP76-YFP microclusters (left; green in 
right image) and SLP76–14-3-3 complexes detected by in situ PLA (middle; red in right image) were visualized by confocal microscopy. A z-stack projec-
tion is shown. Bottom image represents an x-z projection of the cells shown in top images. Images are representative of three independent experiments. 
Bars, 5 µm. (B) J14 cells were transiently transfected with SLP76-YFP-WT or -S376A constructs. Cells were activated as in A, fixed, and imaged by con-
focal microscopy. SLP76-YFP microclusters were automatically counted (see Materials and methods) in cells expressing comparable levels of YFP labeling. 
Horizontal lines and error bars show means and SEM. (C) J14-SLP76-WT cells stably expressing FLAG-SLP76 were stimulated with anti-CD3 mAbs for 
the indicated time points, lysed, and immunoprecipitated (IP) with anti-FLAG mAbs. Samples were sequentially analyzed by GST (left) and GST–14-3-3 
(middle) overlay assays followed by immunoblotting with anti-SLP76 and anti-GADS antibodies (right). Similar results were obtained in four independent 
experiments. Open arrowheads indicate heavy chains of precipitating antibodies. Mobility of molecular mass markers (in kilodaltons) is shown on the left. 
(D) Human CD4
+ T cells were treated as in C, immunoprecipitated with anti-SLP76 antibodies, and subjected to overlay assays and immunoblotting as in C. 
This result is representative of two independent experiments. Mobility of molecular mass markers is shown on the right in kilodaltons.JCB • VOLUME 195 • NUMBER 5 • 2011   846
Figure 5.  HPK1-dependent binding of 14-3-3 to GADS. (A) HPK1-HA constructs, wild type (WT) or kinase deficient (KD), were transfected in COS7 cells 
and immunoprecipitated (IP) with anti-HA mAbs. Recombinant MBP or MBP-GADS was added to either sample and incubated with [
32P]ATP. Supernatants 
were then spotted onto Whatman filters, and incorporated radioactivity was measured. Comparable results have been obtained in three independent 
experiments. Error bars indicate SDs of triplicates. (B) J14-SLP76-WT cells expressing FLAG-SLP76 and transfected with control (siCont) or HPK1-specific 
(siHPK1) siRNAs were stimulated by anti-CD3 mAbs for the indicated time points, lysed, and immunoprecipitated with anti-FLAG mAbs. Samples were 
analyzed by GST (top) and GST–14-3-3 (middle) overlay assay followed by Western blotting with anti-SLP76 and anti-GADS antibodies (bottom).   847 HPK1 regulates T cell microcluster stability • Lasserre et al.
(Brummer et al., 2008). Hence, we mutated Thr254 to Ala in a 
murine GADS construct fused to the CFP (CFP-GADS; Bunnell 
et al., 2006) and tested the ability of this mutant to bind 14-3-3. 
J14 cells were transfected with FLAG-SLP76 alone or together 
with WT or mutant CFP-GADS. Analysis of anti-FLAG immuno-
precipitates  by  an  overlay  assay  revealed  that  GST–14-3-3 
bound in an inducible manner to FLAG-SLP76 and endogenous 
GADS as well as to transfected CFP-GADS (Fig. 6 A, top). Con-
versely, binding of GST–14-3-3 to CFP-GADS-T254A was 
almost undetectable (Fig. 6 A, top). Moreover, an antibody raised 
against phosphorylated RRXp(S/T) motifs detected CFP-GADS 
in a stimulation-dependent manner (Fig. 6 A, middle) but not 
CFP-GADS-T254A, confirming that Thr254 is phosphorylated 
in vivo and demonstrating a causal link between Thr254 phos-
phorylation and GST–14-3-3 binding to GADS.
To assess the relative contribution of SLP76 and GADS 
binding sites to 14-3-3 recruitment, J14 cells were transfected 
with FLAG-SLP76 and CFP-GADS constructs, either WT or 
mutant, in various combinations. Immunoblotting on SLP76 
immunoprecipitates showed that GADS-T254A mutation re-
duced the coprecipitation of 14-3-3 more strongly than the 
SLP76-S376A mutation (Fig. 6 B, bottom). Expression of both 
mutants further reduced 14-3-3 binding (Fig. 6 B, bottom), 
demonstrating  that  stable  interaction  of  14-3-3  with  the 
SLP76–GADS complex depends on both Ser376 and Thr254. 
Importantly, neither mutation altered the constitutive SLP76–
GADS interaction (Fig. 6 B, top and middle). These data identi-
fied Thr254 of GADS as a 14-3-3 binding site and highlighted 
its prominent role in regulating the association of 14-3-3 pro-
teins to SLP76–GADS complexes.
14-3-3 binding to SLP76 and GADS 
cooperatively affects microcluster stability 
and T cell activation
Based on the aforementioned observations, we aimed to corre-
late 14-3-3 binding to SLP76 and GADS with microcluster sta-
bility and T cell activation. First, we analyzed the persistence of 
SLP76 microclusters in cells expressing various SLP76-YFP 
and  CFP-GADS  constructs  stimulated  on  anti-CD3–coated 
coverslips for 5 min. The number of SLP76 microclusters was 
significantly  increased  in  cells  expressing  the  CFP-GADS-
T254A  compared  with  those  transfected  with  CFP-GADS   
(Fig. 7 A). Expression of YFP-SLP76-S376A also increased the 
number of microclusters compared with YFP-SLP76–expressing 
cells, although it was less effective than CFP-GADS-T254A 
(Fig. 7 A). Simultaneous expression of both mutants further in-
creased the number of microclusters as compared with either 
mutant alone (Fig. 7 A). Of note, phospho-LAT microclusters 
kinase assay to test whether GADS is a substrate of HPK1.   
Immunoprecipitated WT or kinase-deficient HPK1 was incubated 
with maltose-binding protein (MBP) or an MBP-GADS fusion 
protein in the presence of [
32P]ATP. A significant incorporation 
of 
32P over background was observed when MBP-GADS was 
incubated with WT HPK1 but not with the kinase-deficient con-
struct (Fig. 5 A).
We then asked whether HPK1 regulates the interaction of 
14-3-3 with GADS. We transfected J14-SLP76-WT cells with 
control or HPK1-specific siRNAs and immunoprecipitated 
FLAG-SLP76 and associated proteins. Efficient HPK1 knock-
down (Fig. S3 C) almost completely inhibited of GST–14-3-3 
binding to FLAG-SLP76 in an overlay assay (Fig. 5, B [middle] 
and C [left]). Maximum binding of GST–14-3-3 to GADS was 
reduced by 50% in HPK1 knockdown cells compared with 
control cells (Fig. 5, B [middle] and C [right]). Although the in-
hibition of GST–14-3-3 binding to GADS in this assay was not 
complete, this result indicated a role of HPK1 in inducing 14-3-3 
binding to GADS.
Finally, we probed the role of HPK1 in regulating the inter-
action of 14-3-3 with GADS in intact cells. Jurkat cells, trans-
fected with control or HPK1-specific siRNAs, were stimulated 
on anti-CD3–coated coverslips and analyzed by in situ PLA with 
different antibody combinations. Labeling with anti-SLP76 and 
anti–14-3-3 antibodies yielded a positive PLA signal that was 
abolished upon HPK1 silencing (Fig. 5, D [top] and E), confirm-
ing that SLP76 binding to 14-3-3 is induced by HPK1 (Di   
Bartolo et al., 2007). Staining with anti-GADS and anti–14-3-3 
antibodies also yielded a strong PLA signal in control cells, vali-
dating  the  interaction  between  these  proteins,  which  was   
impaired by HPK1 silencing (Fig. 5, D [middle] and E). Con-
versely, no detectable PLA signal was observed after staining 
with anti-LAT and anti–14-3-3 antibodies (Fig. 5, D [bottom] 
and E). Collectively, these data demonstrated that HPK1 controls 
the interaction of 14-3-3 proteins with GADS.
14-3-3 binds a phosphothreonine-
containing motif of GADS
Because 14-3-3 protein binding to their target is usually induced 
by Ser/Thr phosphorylation of conserved motifs (Tzivion and 
Avruch, 2002), we inspected the human GADS sequence in 
search of potential 14-3-3 binding sites. We identified a conserved 
RRHTDP sequence, resembling a type I 14-3-3 binding motif 
(RXXp(S/T)XP;  Johnson  et  al.,  2010),  encompassing  Thr262 
(Thr254 in murine GADS). Interestingly, this residue was previ-
ously reported to be phosphorylated in T cells (Salomon et al., 
2003; Brill et al., 2004), and a similar motif in the adaptor Gab2 
(RRNpTLP) was previously shown to bind 14-3-3 proteins 
Similar results have been obtained in three independent experiments. Open arrowheads indicate heavy chains of the precipitating antibodies. HPK1 knock-
down efficiency was assessed by immunoblotting (Fig. S1 C). Mobility of molecular mass markers is shown on the right in kilodaltons. (C) Quantification 
of GST–14-3-3 binding to SLP76 (left) and GADS (right) in overlay assays shown in B. Bands in B (middle and bottom) were acquired and quantified as 
outlined in Materials and methods. Intensity of bound GST–14-3-3 bands was normalized by the relative amount of SLP76 (left) or GADS (right) in the 
same lane. (D) Jurkat cells transfected with control or HPK1-specific siRNAs were activated for 10 min on anti-CD3–coated coverslips, fixed, and stained 
with the antibody pairs indicated on the left and by DAPI for visualizing nuclei (blue). Protein complexes (red) were detected by in situ PLA. A z-stack projec-
tion is shown in each image. Bars, 5 µm. (E) Images obtained by in situ PLA experiments as shown in D were analyzed using the BlobFinder software to 
automatically count spots generated by protein–protein interactions. Histograms show means and SEM of the number of spots per cell from two independent 
experiments. The number of cells analyzed is indicated beside each bar.
 JCB • VOLUME 195 • NUMBER 5 • 2011   848
Discussion
This work shows for the first time that HPK1 modulates TCR-
proximal signaling and T cell activation by regulating the stabil-
ity of critical protein complexes at the immunological synapse. 
We found that the persistence of SLP76 microclusters induced 
by TCR stimulation is dependent on HPK1 activity. HPK1 in-
corporation into SLP76 microclusters coincides with their rapid 
dissipation caused by a 14-3-3–mediated uncoupling of SLP76–
GADS complexes from LAT. Persistence of phospho-LAT   
microclusters appears also affected by HPK1 but with some delay 
compared with SLP76 microclusters. These kinetic differences 
suggest that the effect on phospho-LAT clustering is consequent 
to the release of the SLP76–GADS complex, possibly because 
of the loss of stabilizing protein–protein interactions dependent 
on SLP76 and/or GADS. In support of the hypothesis that HPK1 
does not target LAT directly, phospho-LAT microclusters are 
increased when 14-3-3 binding to SLP76 and GADS is impaired 
(Fig. S5 A). Collectively, these results show that a major func-
tion of HPK1 is to uncouple the SLP76–GADS from phosphory-
lated LAT, leading to negative regulation of T cell activation.
The results described here reveal that the mechanism of 
HPK1-dependent tuning of TCR-proximal signaling is more 
complex than initially reported because it involves a previously 
unidentified 14-3-3 binding site in GADS in addition to Ser376 
were also increased at this time point by SLP76 and GADS mu-
tations (Fig. S5 A), indicating that alterations of these two adap-
tors indirectly affect LAT clustering.
Finally, we evaluated the functional response of T cells 
expressing SLP76 and GADS mutants by measuring the activa-
tion of the nuclear factor of activated T cell (NFAT) transcrip-
tion factor. J14-SLP76-WT and -S376A cell lines expressing 
FLAG-tagged WT SLP76 or the S376A mutant (Di Bartolo   
et al., 2007) were transfected with CFP-GADS or CFP-GADS-
T254A expression vector, together with an NFAT-luciferase   
reporter plasmid. Measurement of luciferase activity in cells 
stimulated with anti-CD3 and anti-CD28 antibodies showed 
that  overexpressing  CFP-GADS-T254A  in  J14-SLP76-WT 
cells led to higher NFAT activation than CFP-GADS transfec-
tion (Fig. 7 B). J14-SLP76-S376A cells expressing CFP-GADS 
also showed higher NFAT activity compared with J14-SLP76-
WT transfected with this construct. Moreover, expression of 
CFP-GADS-T254A in J14-SLP76-S376A further increased 
NFAT activity (Fig. 7 B), indicating that simultaneous mutation 
of both 14-3-3 binding sites resulted in the highest T cell activa-
tion. Comparable expression of all constructs was verified by 
immunoblotting (Fig. S5 B). Altogether, these results indicated 
that the simultaneous interaction of 14-3-3 to SLP76 and GADS 
negatively regulates the stability of signaling complexes and 
functional activation of T cells.
Figure 6.  Mutation of Thr254 impairs 14-3-3 binding to 
GADS  and  coprecipitation  with  the  SLP76–GADS  complex. 
(A) J14 cells were transiently transfected with FLAG-SLP76 
together with CFP-GADS constructs, either wild type (WT) or 
T254A. Cells were stimulated (+) or not stimulated () with 
anti-CD3 mAbs, immunoprecipitated (IP) with anti-FLAG anti-
bodies, and analyzed by GST–14-3-3 overlay assay (top) 
followed by immunoblotting (IB) with the antiphospho-RRXS/T 
motif (middle) and anti-FLAG plus anti-GADS mAbs (bottom). 
(B) J14 cells were transiently transfected with FLAG-SLP76-WT 
or -S376A together with either CFP-GADS-WT or CFP-GADS-
T254A. Cells were treated as in A, immunoprecipitated with 
anti-FLAG antibodies, and then analyzed by immunoblotting 
with anti-SLP76 (top), anti-GADS (middle), and 14-3-3 anti-
bodies (bottom). For both panels, data are representative of 
two independent experiments giving similar results. Mobil-
ity of molecular mass markers (in kilodaltons) is shown on   
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of SLP76 (Di Bartolo et al., 2007). Thr254 in murine GADS 
(corresponding to Thr262 in the human protein) was necessary 
for 14-3-3 binding and for negative regulation of microclus-
ter stability and T cell activation. Moreover, disruption of this   
14-3-3 binding site had a stronger impact on SLP76 micro-
cluster persistence than mutation of Ser376, possibly because 
binding of 14-3-3 to GADS disturbs the interaction of the SH2 
domain of GADS with phospho-LAT, either by steric hindrance 
or by inducing a conformational change. However, simultane-
ous mutation of both Ser376 and Thr254 had additive effects on 
both persistence of SLP76 microclusters and NFAT transcrip-
tional activity upon T cell stimulation, suggesting a cooperative 
stabilization of the interaction of 14-3-3 with the SLP76–GADS 
complex. This finding is consistent with 14-3-3 proteins form-
ing homo- and heterodimers that usually require interaction 
with two phosphorylation sites for stable binding (Tzivion and 
Avruch, 2002). Based on these results, we propose a model 
whereby recruitment of HPK1 in SLP76-containing micro-
clusters leads to phosphorylation of both SLP76 and GADS on 
Ser376 and Thr262, respectively. These posttranslational modi-
fications enable recruitment of a 14-3-3 protein dimer, which in 
turn enforces dissociation of the SLP76–GADS–14-3-3 com-
plex from phospho-LAT and consequently down-regulates 
TCR-induced signal transduction (Fig. 8).
The subsequent fate of the pool of SLP76 (and GADS) re-
leased from microclusters is unknown yet. Although a fraction 
of it could still be signaling competent because of its interaction 
with other effectors (Bunnell et al., 2006), the correlation be-
tween removal from microclusters and reduced T cell activation 
reported here rather hints at an inactivation process. Hence,   
14-3-3–bound SLP76 might be sorted for degradation or re-
cycling. We could not detect significant changes in the total 
amount of SLP76 during the stimulation time analyzed (10 min), 
but we cannot exclude that degradation occurs later. Reincorpo-
ration of SLP76 into new microclusters has been previously   
described by others (Barr et al., 2006), but according to our model, 
it  would  imply  release  of  14-3-3  and  dephosphorylation  of 
Ser376. However, we found that both Ser376 phosphorylation 
and 14-3-3 binding to SLP76 were long lasting (i.e., 45–60 min; 
Di Bartolo et al., 2007) and that no additional microclusters 
were generated after the extinction of the first wave accom-
panying cell spreading on anti-CD3 coverslips in cells over-
expressing HPK1 (Fig. 2 A and Video 1). Both observations 
argue against a recycling of released SLP76; hence, further studies 
are required to address these issues.
Intriguingly, HPK1 knockdown more potently impaired 
GST–14-3-3 binding to SLP76 than to GADS in the overlay 
and in situ PLA assays, whereas direct mutation of the 14-3-3 
binding site in GADS had stronger effects on 14-3-3 coprecip-
itation and on microcluster stability than mutation in SLP76. 
The reason for this difference is unknown and may depend, in 
part,  on  the  different  assay  used.  However,  although  HPK1 
phosphorylates GADS in vitro, they do not allow us to exclude 
the existence of redundant kinases that may replace HPK1 in 
phosphorylating GADS in vivo.
The effect of HPK1 on microcluster persistence is remi-
niscent  of  that  previously  described  for  the  ubiquitin  E3   
Figure 7.  Mutation of 14-3-3 binding sites of SLP76 and GADS leads to 
additive increase in SLP76 microclusters and NFAT activation. (A) J14 cells 
were transiently transfected with SLP76-YFP, -WT, or -S376A together with 
CFP-GADS constructs, either WT or a T254A mutant. Cells were stimulated 
for 5 min on anti-CD3–coated coverslips, fixed, and imaged by confocal 
microscopy. The number of SLP76 microclusters was automatically assessed 
in selected cells showing homogeneous levels of YFP and CFP fluorescence. 
A similar analysis was performed on phospho-LAT microclusters (Fig. S5 A). 
Horizontal lines and error bars show means and SEM. (B) J14 cells stably 
expressing  FLAG-SLP76  (J14-WT)  or  FLAG-SLP76-S376A  (J14-S376A) 
were transiently cotransfected with the indicated CFP-GADS construct and 
an NFAT-luciferase reporter plasmid. Cells were stimulated with the in-
dicated concentrations of plate-bound anti-CD3 and 1 µg/ml of soluble 
anti-CD28 mAbs for 5 h. Control samples were stimulated with PMA and 
Ca
2+ ionophore to assess maximal NFAT-dependent transcription. Lucifer-
ase activity was measured in cell lysates. Data represent means ± SD of 
normalized luciferase activity from quadruplicate samples expressed as a 
percentage of maximal luciferase activity. Comparable expression levels 
of all constructs are shown in Fig. S5 B.JCB • VOLUME 195 • NUMBER 5 • 2011   850
responses (Alzabin et al., 2010). Interestingly, anti-CD3–stimulated   
binding of GST–14-3-3 to GADS in vitro is reinforced by pre-
treating Jurkat cells with PGE2 (unpublished data). Hence, it will 
be interesting to address the involvement of HPK1-dependent 
control of microclusters in altering T cell responsiveness under 
pathological conditions.
In conclusion, our data demonstrate that negative feedback 
triggered by HPK1 plays an important role in regulating the stabil-
ity of critical signaling complexes at immunological synapses. This 
mechanism may represent a flexible device adapting T cell respon-
siveness according to cell differentiation and/or external cues.
Materials and methods
Plasmids and antibodies
The pEF-FLAG-SLP76-WT expression vector was provided by G. Koretzky 
(University of Pennsylvania, Philadelphia, PA). pMT2-HPK1-HA and pMT2-
HPK1-KD-HA plasmids (Arnold et al., 2005) were provided by F. Kiefer 
(Max Planck Institute for Molecular Biomedicine, Münster, Germany). 
HPK1-MYC and -mCherry constructs were generated by subcloning mouse 
HPK1 cDNA from pMT2-HPK1-HA plasmids into the pmCherry-N1 plasmid 
(Takara Bio Inc.) using a PCR cloning system (In-Fusion; Takara Bio Inc.). 
SLP76-YFP and CFP-GADS (Bunnell et al., 2006) were provided by L.E. 
Samelson (National Cancer Institute–Center for Cancer Research, Bethesda, 
MD). All point mutations were generated using the mutagenesis kit (Quik-
Change II; Agilent Technologies) and verified by sequencing of the entire 
insert cDNA. The following antibodies were used: 14-3-3 (C-16; Santa 
Cruz Biotechnology, Inc.), SLP76 (clone SLP76/03 mAb or goat polyclonal 
obtained from AbD Serotec and rabbit polyclonal obtained from Cell Sig-
naling Technology), HPK1 (Cell Signaling Technology), FLAG (M2; Sigma-
Aldrich), CD3 (clone UCHT1 obtained from BioLegend, MEM92 obtained 
ligase c-Cbl (Balagopalan et al., 2007). Indeed, c-Cbl incorpo-
ration  into  LAT-  and  SLP76-containing  microclusters  induces 
their dissipation, although the mechanisms allowing c-Cbl–
dependent control of microcluster stability remain to be identified 
(Balagopalan et al., 2007, 2011). Therefore, HPK1 and c-Cbl ap-
pear to modulate microcluster persistence, likely by different 
mechanisms, suggesting that multiple negative feedback loops op-
erate to control protein clustering at immunological synapses. This 
also implies that the dissipation of signaling protein complexes is 
not only dictated by “passive” mechanisms, e.g., stochastic release 
of SH2-mediated interactions followed by dephosphorylation 
of critical tyrosine residues, but also by specific mechanisms 
“actively” driving the dissociation of key components.
Tuning of T cell signaling by HPK1 might be regulated in 
an activation- and/or differentiation-dependent fashion. Indeed, 
it has been shown that the expression of HPK1 in stimulated   
T cells is first up-regulated and then decreased because of cas-
pase-dependent cleavage. Such modulation appears to control 
the activation of the NFB pathway, thus inducing a change in 
T cell sensitivity to activation-induced apoptosis (Brenner   
et al., 2005), but it may also affect upstream signaling events. If 
this is the case, the regulatory mechanism described here would 
be active in naive but not in previously activated cells.
TCR-independent stimuli may also tune HPK1 activity 
and, consequently, T cell responsiveness. For instance, it has 
been proposed that secretion of prostaglandin E2 by cancer cells 
activates HPK1 and impairs CD8
+ T cell–dependent antitumor   
Figure 8.  Model of regulation of microcluster persistence and signaling by HPK1. (A) SLP76–GADS complexes (only one is depicted for clarity) are 
recruited to the phosphorylated transmembrane adaptor LAT to form signaling-competent microclusters. (B and C) When phosphorylated on Tyr379, 
HPK1 is incorporated into microclusters by interacting with the SH2 domain of SLP76 (B) and phosphorylates Ser376 of SLP76 and Thr262 of GADS (C).   
(D and E) 14-3-3 proteins then bind to SLP76–GADS complexes through these phosphorylated residues (D), thus leading to dissociation of these complexes 
from phospho-LAT (p-LAT) and terminating signaling (E).851 HPK1 regulates T cell microcluster stability • Lasserre et al.
in 96-well plates. After 5 h, cells lysis and luciferase activity assays were 
performed using the Cell Culture Lysis Reagent and the Luciferase Assay 
System (Promega) according to the manufacturer’s instructions. Plates were 
read using a microplate luminometer (Tropix TR717; Applied Biosystems). 
The percentage of luciferase activity for anti-CD3/CD28-stimulated samples 
was calculated as follows: percent = [(RLU  MIN)/(MAX  MIN)] × 100, 
in which RLU is the measured luciferase activity of the sample, MIN is the 
mean RLU for the unstimulated sample, and MAX is the mean RLU for a sam-
ple stimulated with PMA plus Ca
2+ ionophore.
PLA
This assay allows detection of protein–protein interactions when two anti-
bodies coupled to complementary oligonucleotides are in sufficient proxim-
ity to allow annealing and priming of a rolling circle amplification reaction. 
Amplification products are then visualized by incubation with fluorescent 
probes. Interactions between 14-3-3 and potential targets were analyzed 
in situ by intracellular labeling with anti–14-3-3 rabbit polyclonal anti-
body combined with anti-SLP76, anti-GADS, or anti-LAT mouse mAbs fol-
lowed by detection using the PLA kit (Duolink; Olink) according to the 
manufacturer’s instructions. Fluorescence spots generated were automati-
cally counted, and the mean number of spots per cell was calculated from 
nuclei counting using BlobFinder V3.2 software (Centre for Image Analy-
sis, Uppsala University, Uppsala, Sweden).
Transient transfection and RNA interference
For transient protein expression, cells were electroporated with 5–15 µg 
plasmid using an electroporation device (260 V, 950 µF; Gene Pulser 
Xcell; Bio-Rad Laboratories), a Neon transfection system, or a Nucleofector 
system (Lonza). HPK1 knockdown in cell lines was obtained by electropo-
rating 500 nM of control or HPK1-specific siRNAs (Thermo Fisher Scien-
tific) as previously described (Lasserre et al., 2010). CD4
+ T cells were 
transfected with 1 µM siRNA using a Nucleofector system and the Human 
T  Cell  Nucleofector  kit  (Lonza).  Cells  were  analyzed  72–96  h  after 
transfection.
Cell stimulation and lysis, immunoprecipitation, and immunoblotting
Cells were stimulated by incubation at 37°C with 15 µg/ml of soluble anti-
CD3 mAb (IgM, clone MEM-92). Activation was stopped by adding ice-
cold  PBS  containing  2  mM  sodium  orthovanadate  and  0.05%  sodium 
azide. Cells were lysed for 10 min in ice-cold buffer containing 0.25%   
lauryl--maltoside and a cocktail of protease and phosphate inhibitors, and 
insoluble material was removed by centrifugation at 20,800 g for 10 min 
at 4°C. Immunoprecipitations were performed by incubating lysates for 
1.5–2 h at 4°C with either anti-FLAG M2 affinity gel (Sigma-Aldrich) or 
protein G–coupled Sepharose beads previously coated with relevant anti-
bodies. Beads were then washed, and bound proteins were eluted by incu-
bating beads with a 0.2 mg/ml FLAG peptide (Sigma-Aldrich) solution or 
by heating them at 70°C in gel sample loading buffer. Protein electropho-
resis was performed on standard SDS-PAGE or NuPAGE gels (Invitrogen). 
After protein electrotransfer on nitrocellulose (LI-COR Biosciences), immuno-
blots were saturated with blocking buffer for near-infrared fluorescent west-
ern blotting (Rockland Immunochemicals) and incubated with primary 
antibodies. After incubation with secondary antibodies Alexa Fluor 680 
(Invitrogen), IRDye 800 (Rockland Immunochemicals), or DyLight 800 
(Thermo Fisher Scientific), near-infrared fluorescence was detected and 
quantified by using an Odyssey scanner and the Odyssey v3.0 software 
(LI-COR Biosciences).
Overlay assay
Immunoprecipitated  proteins  were  transferred  onto  nitrocellulose  mem-
branes that were sequentially incubated in renaturation buffer (20 mM 
Hepes, 50 mM NaCl, 1 mM EDTA, and 10% glycerol) containing decreas-
ing  amounts  of  guanidine  hydrochloride  (6–0.19  M).  After  extensive 
washes in renaturation buffer, membranes were saturated as described for 
immunoblottings and incubated overnight with 10 µg/ml GST or GST– 
14-3-3 (provided by Y.-C. Liu, La Jolla Institute for Allergy and Immunol-
ogy, La Jolla, CA; Di Bartolo et al., 2007) followed by mouse anti-GST 
antibody and Alexa Fluor 680– or IRDye 800–coupled anti–mouse anti-
bodies (see previous paragraph).
In vitro phosphorylation assays
WT or kinase-dead HA-tagged HPK1 was expressed in COS7 cells and 
purified by immunoprecipitation with an anti-HA mAb. Human GADS was 
subcloned into pMal C5X (New England Biolabs, Inc.), and the MBP fusion 
protein or MBP alone was bound on an amylose column (New England   
Biolabs, Inc.) and eluted with maltose according to the manufacturer’s in-
from Exbio, or HIT-3a obtained from eBioscience), CD28 (clone CD28.2; 
Beckman  Coulter),  phospho-SLP76  (Y128;  clone  J141-668-36-58;  BD), 
phospho-LAT (Y191; rabbit polyclonal; Cell Signaling Technology), anti-
GADS (rabbit polyclonal obtained from Millipore or mAb obtained from 
Santa Cruz Biotechnology, Inc.), and anti-RRXp(S/T) motif (100G7E; rab-
bit mAb) obtained from Cell Signaling Technology.
Cells
SLP76-deficient J14 cells (provided by A. Weiss, University of California, 
San Francisco, San Francisco, CA; Yablonski et al., 1998) were cultured 
in RPMI 1640 medium supplemented with 10% FCS and antibiotics. J14-
SLP76-WT and J14-SLP76-S376A cells (Di Bartolo et al., 2007) were ob-
tained by infecting J14 cells with pseudotyped viral particles bearing a 
bicistronic  pMX-IRES-GFP  retroviral  vector  coding  for  SLP76  constructs,   
either WT or S376A, respectively. Two rounds of infection were performed 
followed by enrichment of GFP-positive cells by fluorescence-activated cell 
sorting.  These  cells  were  cultured  in  the  aforementioned  medium.  J14-
SLP76-YFP, a cell line expressing SLP76-YFP (Lasserre et al., 2010), was 
generated by transfecting J14 cells with an SLP76-YFP–expressing plasmid 
(see  Plasmids  and  antibodies  section)  by  electroporation.  Stably  trans-
fected cells were selected and maintained in culture medium supplemented 
with 1 mg/ml G418 (Invitrogen). Human CD4
+ T cells were isolated from 
peripheral blood of healthy donors using the CD4
+ T Cell Isolation Kit II 
(Miltenyi Biotec) and cultured in RPMI 1640 medium containing 10% FCS, 
1 mM sodium pyruvate, nonessential amino acids, antibiotics, and 2 ng/ml 
IL-7 (Hung et al., 2007). Human dendritic cells were obtained by purifica-
tion of monocytes from the peripheral blood of healthy donors using a 
CD14
+  cell  isolation  kit  and  7-d  culture  in  medium  supplemented  with   
20 ng/ml granulocyte macrophage colony-stimulating factor and 1,000 U/ml 
IL4. For T cell stimulations, dendritic cells were matured using lipopolysac-
charide for 24 h.
Confocal microscopy and image analysis
SLP76 and LAT microclusters were studied as previously described (Lasserre   
et al., 2010). In brief, cells were dropped onto glass coverslips (MatTek or 
LabTek) coated with anti-CD3 mAb (UCHT-1, MEM-92, or HIT-3a) or on   
superantigen-pulsed dendritic cells. Live cells were imaged at 37°C in RPMI 
1640 medium without phenol red supplemented with 10% FCS, using a 
spinning-disk  confocal  microscope  (UltraVIEW;  PerkinElmer)  equipped 
with a stage and objective heater and CO2 incubator. Z stacks of 11 con-
focal sections were acquired every 5 s for 5 min or every 20 s for 20 min 
for stimulation with dendritic cells. Alternatively, cells were fixed at the in-
dicated  times,  permeabilized,  stained  with  the  appropriate  antibodies, 
and then analyzed by a confocal microscope (LSM700 [Carl Zeiss]; SP5 
[Leica]) using a 63× oil immersion objective with a 1.4 numerical aperture. 
Secondary antibodies were labeled with Alexa Fluor 488 (green fluores-
cence channel), Cy3 (red), or Cy5 (far red). Depending on the microscope, 
images were acquired using Zen (Carl Zeiss), LAS AF Lite (Leica), or Voloc-
ity (PerkinElmer) software. Postacquisition treatment of images was per-
formed using ImageJ software (National Institutes of Health).
TIRF microscopy
Cells  were  stimulated  on  anti-CD3–coated  coverslips  (Laboratory-Tek; 
Thermo Fisher Scientific), fixed, labeled, kept in PBS supplemented with   
20 mM ascorbic acid (Sigma-Aldrich), and then analyzed using TIRF with 
an inverted microscope (IX81; Olympus).
Quantitative image analysis of microclusters and statistical analysis
A specific script for automated detection and counting of microclusters was 
created using the Acapella 2.0 image analysis software (PerkinElmer). For 
antibody-based microcluster detection, a threshold has been introduced 
based on the mean signal measured on unstimulated cells plated on poly-
l-lysine. Microcluster lifetime was measured by analyzing videos using the 
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